To scroll text in this page

Global Navigation

About Astellas

Start of the main text

Products Introduction

Product for the global market



Prograf® is an immunosuppressant used to prevent rejection in organ transplants. It is sold in about hundred countries around the world. Used by many transplant recipients in the United States, where organ transplant is widely performed, Prograf® has built an enduring position in transplant medicine.


Vesicare®(VESIcare® in the United States)

Vesicare®, a treatment for overactive bladder, acts by blocking the muscarinic receptors in bladder smooth muscle to improve symptoms such as urinary frequency, urgency and urge incontinence associated with overactive bladders. Launched in Europe in 2004, it is now marketed in over seventy countries.

image:Protopic®Protopic® Protopic® is the world's first treatment for atopic dermatitis in the topical immunomodulator class. It reduces inflammation by inhibiting the body's production of cytokine and suppressing allergic responses. It is marketed in about seventy countries around the world.

image:Harnal®Harnal® (Flomax®, Omnic®, and Omnic OCAS® in the United States and Europe)
Harnal® is an α1 blocking agent with great selectivity for prostatic and urethral smooth muscle, to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder. Now marketed in hundred countries around the world, it is the global standard in BPH treatment.

image:Funguard®Funguard® (Mycamine® in the United States and Europe)
A candin antifungal agent, Funguard® operates on a new mechanism, inhibiting synthesis of the fungus cell wall. It combines both outstanding clinical effectiveness and high safety. It is marketed in about forty countries around the world.

Leading Products in Japan

  • Geninax® : an oral new-type quinolone antibacterial agent
  • Celecox® : the selective COX-2 lnhibitor
  • Lipitor® : a treatment for hypercholesterolemia
  • Micardis® : a treatment for hypertension
  • Gaster® : a treatment for peptic ulcers and gastritis
  • Myslee® : a hypnotic
  • Cefzon® : an oral cephalosporin
  • Seroquel® : an antipsychotic agent
  • Dorner® : a treatment for chronic arterial occlusion
  • Nasea® : a 5-HT3 (receptor) antagonist
  • Regnite® : a treatment for restless legs syndrome
  • Kiklin® : a treatment for hyperphatemia

Leading Products in North America

  • LexiscanTM : a pharmacologic stress agent
  • Adenoscan® : a pharmacologic stress agent
  • Tarceva® : a treatment for non-small cell lung cancer
  • Vaprisol® : a treatment for euvolemic hyponatremia
  • AmBisome® : a systemic antifungal agent

Leading Products in Europe

  • Eligard® : a treatment for advanced prostate cancer
  • Locoid® : a topical corticosteroid
  • Zineryt® : a treatment for acne
  • Locobase® : a treatment for dry skin
  • DificlirTM : a novel treatment for CDI

Main Text end
Local Navigation
Local Navigation end
Related Links